News

Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly “bribing” providers to prescribe its ...
The rapid adoption of GLP-1 receptor agonists has fundamentally altered obesity management, with these medications now ...
WW International, the company known as WeightWatchers, brought back its full-year outlook when it reported second-quarter ...
One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?
Researchers suggest all diabetes patients on weight-loss drugs should be regularly screened and monitored for potential eye ...
Danone has launched a drinkable yogurt product under its Oikos brand in the US which looks to target users of Ozempic and ...
The FDA said it's taking action to protect patients from unapproved animal-derived thyroid medications and expressed concern over the use of unapproved GLP-1 receptor agonists for weight loss, such as ...
People who took the daily pill orforglipron lost 12 percent of body weight on average after 72 weeks, according to clinical trial results from Lilly.
More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...
Danone is launching Oikos Fusion, a dairy-based drink targeting U.S. consumers using weight loss medications like Wegovy.
Drugs such as Ozempic, Wegovy and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage ...
The partnership means that Apple's fitness and wellness service will be made available to all members who enrol onto ...